We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.22B
AUM Growth
+$482M
Cap. Flow
+$240M
Cap. Flow %
4.6%
Top 10 Hldgs %
19.75%
Holding
612
New
43
Increased
206
Reduced
112
Closed
24

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$27.2M
2
SPGI icon
S&P Global
SPGI
+$27.1M
3
NVDA icon
NVIDIA
NVDA
+$15.6M
4
EWBC icon
East-West Bancorp
EWBC
+$10.9M
5
DG icon
Dollar General
DG
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 30.95%
2 Healthcare 19.29%
3 Consumer Discretionary 12.18%
4 Industrials 8.84%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
451
Relay Therapeutics
RLAY
$4.3B
$368K 0.01%
23,100
AFYA icon
452
Afya
AFYA
$1.27B
$366K 0.01%
33,191
+5,000
+18% +$65.6K
LSCC icon
453
Lattice Semiconductor
LSCC
$18.3B
$365K 0.01%
+3,900
New +$321K
PFG icon
454
Principal Financial Group
PFG
$24.7B
$363K 0.01%
4,900
AWI icon
455
Armstrong World Industries
AWI
$7.78B
$361K 0.01%
5,200
+1,500
+41% +$112K
GL icon
456
Globe Life
GL
$14.4B
$351K 0.01%
3,200
+1,800
+129% +$211K
VCYT icon
457
Veracyte
VCYT
$3.71B
$350K 0.01%
17,000
AUTL
458
Autolus Therapeutics
AUTL
$532M
$343K 0.01%
195,000
EPR icon
459
EPR Properties
EPR
$4.7B
$338K 0.01%
9,100
+2,000
+28% +$79.7K
RRX icon
460
Regal Rexnord
RRX
$11.9B
$337K 0.01%
2,424
+170
+8% +$24.6K
BCRX icon
461
BioCryst Pharmaceuticals
BCRX
$2.36B
$336K 0.01%
40,000
ALB icon
462
Albemarle
ALB
$14.8B
$334K 0.01%
1,500
-22,700
-94% -$5.59M
AEL
463
DELISTED
American Equity Investment Life Holding Company
AEL
$328K 0.01%
9,100
+4,800
+112% +$204K
VEEV icon
464
Veeva Systems
VEEV
$35.4B
$322K 0.01%
1,800
MORF
465
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$317K 0.01%
8,500
SWTX
466
DELISTED
SpringWorks Therapeutics
SWTX
$314K 0.01%
12,300
AVY icon
467
Avery Dennison
AVY
$13.2B
$313K 0.01%
1,800
-1,600
-47% -$291K
LGND icon
468
Ligand Pharmaceuticals
LGND
$6.02B
$307K 0.01%
4,300
BCYC
469
Bicycle Therapeutics
BCYC
$278M
$305K 0.01%
14,000
SWKS icon
470
Skyworks Solutions
SWKS
$10.1B
$304K 0.01%
2,576
-1,030
-29% -$114K
ADPT icon
471
Adaptive Biotechnologies
ADPT
$3.75B
$301K 0.01%
35,700
BILI icon
472
Bilibili
BILI
$7.81B
$300K 0.01%
12,000
DG icon
473
Dollar General
DG
$28.1B
$291K 0.01%
1,400
-46,000
-97% -$10.3M
RCKT icon
474
Rocket Pharmaceuticals
RCKT
$387M
$272K 0.01%
16,700
OWL icon
475
Blue Owl Capital
OWL
$7.74B
$260K 0.01%
23,460

Similar funds

Erste Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Erste Asset Management held 612 positions worth $5.22B, up 10% from $4.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Erste Asset Management deployed $240M of net new capital in Q1 2023, opening 43 new positions and adding to 206 existing holdings. Its largest new stake was Nextpower Inc: 635,000 shares worth $22.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Home Depot, an estimated $27.2M trimmed.

  • Erste Asset Management's largest Q1 2023 buy was Nextpower Inc: 635,000 shares worth $22.1M.
  • Erste Asset Management added most to Meta Platforms (Facebook) in Q1 2023, an estimated $37.6M increase.
  • Erste Asset Management's biggest Q1 2023 reduction was Home Depot, cutting an estimated $27.2M.
  • Erste Asset Management fully exited Royal Bank of Canada in Q1 2023, selling an estimated $5.85M.
  • Erste Asset Management's ten largest holdings make up 20% of its $5.22B portfolio in Q1 2023.
  • Erste Asset Management opened 43 new positions and closed 24 in Q1 2023.
  • Erste Asset Management's portfolio value rose 10% quarter-over-quarter to $5.22B.

Based on Erste Asset Management's 13F filing for Q1 2023, filed 26 Nov 2024.